STRAW MAN: Dr.M should however change his methodology and hurry up and look at the interim data anyways.
An interim peek at the alz data has nothing to do with an overall CNS approval and requires no change in methodology.
It may speed it up approval and at the least would get AVXL stock a proper valuation.
PEEVED IS RIGHT:normally a low does not linger unless it lingers for months.
People who want to buy buy it up...often when just above support for some time, they give impression that it is holding but it dumps. you can laugh all you want but if this is a 70 dollar stock and 18.5 is supposed to be the low, most people would buy at 18.5 not allowing it to stay there.
look at SAVA. it dumps big 50%, but jumped right back up...
we dumped 50% and still stagnant.
EXACTLY. SAVA got right back up after being knocked down because it will have a 12 month data peek soon.
AVXL has nothing BIG for a YEAR at best. An interim peek would solve that problem and get us a proper valuation
Market Data 
Markets 
AI
